SBRANasdaqReal Estate Investment TrustsFiscal year ends December 31

Sabra Health Care REIT, Inc.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 3, 2026

$19.08−0.26 (-1.34%)

Close on Oct 19, 2026

Market cap: $4.81B
P/E (TTM): 73.4
Dividend yield: 6.29%

Sabra Health Care REIT, Inc. income statement

Annual Quarterly TTM

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31	FY 2020 2020-12-31	FY 2019 2019-12-31	FY 2018 2018-12-31	FY 2017 2017-12-31	FY 2016 2016-12-31	FY 2015 2015-12-31	FY 2014 2014-12-31	FY 2013 2013-12-31	FY 2012 2012-12-31	FY 2011 2011-12-31
Revenue	775	703	648	625	570	599	662	623	408	261	239	184	135	103	84
General & Administrative	54	50	47	40	35	33	31	37	32	18	16	24	16	16	14
Operating Expenses	–	–	–	–	–	–	–	–	–	–	2.58	1.93	–	–	–
Interest Expense	112	115	113	105	99	100	127	147	88	65	59	47	40	34	30
Income from Equity Investments	3.93	-0.40	-2.90	-40	-28	-17	-6.80	-5.43	0	0	–	–	–	–	–
Other Non-Operating Income	9.36	4.83	-76	-14	-22	4.48	-12	130	52	4.00	2.10	–	–	–	–
Gain (Loss) on Sale of Assets	–	2.10	-77	-12	11	2.90	2.30	–	–	–	–	–	–	–	–
Pretax Income	153	128	19	22	81	156	79	288	159	71	80	–	–	20	13
Income Tax Expense	1.84	1.01	2.00	1.24	1.85	0.71	3.40	3.01	0.65	1.05	0.75	0	0	0	0
Income from Continuing Operations	–	–	–	–	–	138	69	279	158	70	79	47	34	20	–
Net Income incl. Noncontrolling Interests	156	127	14	–	-113	138	69	–	–	–	–	–	–	–	–
Minority Interest in Earnings	-0.10	0	0	–	0	0	0.02	0.03	-0.02	-0.07	-0.03	-0.04	0	0	–
Net Income	156	127	14	-78	-113	138	69	279	158	70	79	47	34	20	13
Preferred Dividends	–	–	–	–	–	0	0	9.77	10	10	10	10	7.97	0	0
Net Income to Common	–	–	–	–	–	138	69	269	148	60	69	37	26	20	13
EPS (Basic)(per share)	0.64	0.54	0.06	-0.34	-0.52	0.67	0.37	1.51	1.40	0.92	1.11	0.79	0.69	0.53	0.43
EPS (Diluted)(per share)	0.64	0.54	0.06	-0.34	-0.52	0.67	0.37	1.51	1.40	0.92	1.11	0.78	0.68	0.52	0.43
Shares Outstanding (Basic, Weighted)(shares)	241	233	231	231	219	206	187	178	106	65	62	46	38	37	30
Shares Outstanding (Diluted, Weighted)(shares)	244	236	233	231	219	207	188	179	106	66	62	47	38	37	30
Dividend per Share(per share)	1.20	1.20	1.20	1.20	1.20	1.35	1.80	1.80	1.73	1.67	1.60	1.51	1.36	1.32	0.96

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin: –
Operating margin: –
Net margin: 7.6%
Return on equity, FY2025: 5.6%

Financial strength

Current ratio: –
Debt to equity: –
Debt to assets: –
Cash to current liabilities: –

Valuation

P/E ratio: 73.4
Price to sales: 5.60
Price to book: 1.75
Dividend yield: 6.29%